We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mesenchymal Stem Cells: Alterations in Genome (MESSAGE)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00836732
First Posted: February 4, 2009
Last Update Posted: September 30, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Nantes University Hospital
  Purpose
The aim is to study small genetic alterations induced by cell culture in human mesenchymal stem cells in GMP condition.

Condition Intervention
Pened Chest Surgery for Programmes Coronary Bypass Procedure: harvest of a small bone marrow sample

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Official Title: MESenchymal Stem Cells: Alterations in GEnome

Further study details as provided by Nantes University Hospital:

Primary Outcome Measures:
  • Presence of small genetic alteration in mesenchymal stem cells [ Time Frame: one month ]

Enrollment: 35
Study Start Date: November 2008
Study Completion Date: March 2012
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: harvest of a small bone marrow sample
    harvest of a small bone marrow sample during open chest surgery
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age > 18 old
  • age < 75 old
  • opened chest surgery for programmed coronary bypass
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00836732


Locations
France
nantes University Hospital
Nantes, France, 44340
Sponsors and Collaborators
Nantes University Hospital
Investigators
Principal Investigator: Patricia Lemarchand, MD Nantes UH - institut du thorax
  More Information

Responsible Party: Nantes University Hospital
ClinicalTrials.gov Identifier: NCT00836732     History of Changes
Other Study ID Numbers: BRD 08/9-S
First Submitted: February 3, 2009
First Posted: February 4, 2009
Last Update Posted: September 30, 2013
Last Verified: September 2013

Keywords provided by Nantes University Hospital:
celle therapy
cell culture
mesenchymal stem cells